Report of Foreign Issuer (6-k)
June 19 2018 - 6:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of June 2018
Commission File Number:
001-37452
CELYAD SA
(Translation
of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F.
Form
20-F ☒
Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7): ☐
Celyad SA
On June 19, 2018, Celyad SA (the
Company
) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is
incorporated by reference herein.
The information contained in this Current Report on
Form 6-K, including
Exhibit 99.1, except for the quote of Christian Homsy contained in Exhibit 99.1, is hereby incorporated by reference into the Companys Registration Statements on
Forms F-3 (File No. 333-220285) and S-8 (File No.
333-220737).
EXHIBITS
|
|
|
Exhibit
|
|
Description
|
|
|
99.1
|
|
Press release issued by the registrant on June 19, 2018
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD SA
|
|
|
|
|
Date: June 19, 2018
|
|
|
|
By:
|
|
/s/ Patrick Jeanmart
|
|
|
|
|
|
|
Patrick Jeanmart
Chief Financial
Officer
|
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Sep 2023 to Sep 2024